<DOC>
	<DOCNO>NCT02678065</DOCNO>
	<brief_summary>The objective study evaluate performance In.Pact Admiral DEB treatment popliteal lesion comparison literature result stent treatment popliteal lesion</brief_summary>
	<brief_title>In.Pact Flexion , Investigating Performance In.Pact Admiral DEB Popliteal Lesions</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>De novo , restenotic reoccluded lesion locate popliteal artery , without superficial femoral artery involvement Patient present score 2 5 follow Rutherford classification Patient willing comply specify followup evaluation specify time Patient &gt; 18 year old Patient ( legal representative ) understand nature procedure provide write informed consent , prior enrolment study Prior enrollment , guidewire cross target lesion Patient eligible treatment In.Pact Admiral drugeluting balloon The target lesion , visually estimate , maximal length 14 cm categorize either type A B lesion accord TASC II guideline The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion pass standard guidewire manipulation Target vessel diameter visually estimate &gt; 3.5mm &lt; 7.5 mm There angiographic evidence least one vesselrunoff foot , irrespective whether outflow reestablish mean previous endovascular intervention . Presence another stent target vessel place previous procedure Presence aortic thrombosis significant common femoral ipsilateral stenosis Previous bypass surgery limb Patients antiplatelet therapy , anticoagulant thrombolytic drug contraindicate Patients exhibit persistent acute intraluminal thrombus propose lesion site Perforation angioplasty site evidence extravasation contrast medium Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Aneurysm locate level SFA and/or popliteal artery Female patient child bear potential take adequate contraceptive currently breastfeed Life expectancy less twelve month Ipsilateral iliac treatment target lesion procedure residual stenosis &gt; 30 % ipsilateral iliac treatment conduct target lesion procedure Use thrombectomy , atherectomy laser device procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study complete entire follow period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>